Immunovant, Inc.
IMVT
Revenue
0.00
0.000.00%
-Assets
420.93M
▼-94.78M▼-18.38%
3 Months ChangeLiabilities
68.32M
▲1.66M▲2.49%
3 Months ChangeFree Cash Flow
-76.38M
▼-28.97M▼-61.09%
12 Months ChangeRevenue/Cost Of Revenue
Loading...
Net Profit/Loss
Loading...
Assets/Liabilities
Loading...
Cash Flows
Loading...
Loading...
Loading...
Recent Quarterly and Annual Filings
2024-09-09
Form 8-K
ID: 0001764013-24-000162
2024-08-13
Form 8-K
ID: 0001764013-24-000150
2024-08-06
Form 10-Q
ID: 0001764013-24-000148
2024-08-06
Form 8-K
ID: 0001764013-24-000147
2024-05-29
Form 8-K
ID: 0001764013-24-000107
2024-02-12
Form 10-Q
ID: 0001764013-24-000026
2024-02-12
Form 8-K
ID: 0001764013-24-000025
2024-01-09
Form 8-K
ID: 0001764013-24-000003
2023-12-20
Form 8-K
ID: 0001764013-23-000159
2023-11-28
Form 8-K
ID: 0001764013-23-000150